8-K - Akari Therapeutics Plc (0001541157) (Filer)
据 SEC EDGAR 8-K 文件，Akari Therapeutics Plc（CIK 0001541157）于 2026-10-30 提交 8-K，报告期为 2026-10-28，共 12 份文件。
报错 · 内容有误？请告诉我们。
Filing Date
2026-10-30
Accepted
2026-10-30 16:45:16
Documents
12
Period of Report
2026-10-28
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits
Mailing Address 401 EAST JACKSON STREET SUITE 3300 TAMPA FL 33602
Business Address 401 EAST JACKSON STREET SUITE 3300 TAMPA FL 33602 (929) 274-7510
Akari Therapeutics Plc (Filer) CIK: 0001541157 (see all company filings)
EIN.: 981034922 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36288 | Film No.: 261508627
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)
来源：SEC EDGAR 8-K · sec.gov